Literature DB >> 20197569

More on the resolution of bisphosphonate-associated osteonecrosis of the jaw.

Kuo-Yang Tsai, Chin-Sheng Huang, Guan-Min Huang, Chen-Tung Yu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20197569     DOI： 10.3899/jrheum.091022

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  5 in total

Review 1.  Lack of response to teriparatide therapy for bisphosphonate-associated osteonecrosis of the jaw.

Authors:  J Narváez; J A Narváez; C Gómez-Vaquero; J M Nolla
Journal:  Osteoporos Int       Date:  2012-03-08       Impact factor: 4.507

2.  Teriparatide's role in the management of bisphosphonate-associated osteonecrosis of the jaw.

Authors:  G Subramanian; S Y P Quek
Journal:  Osteoporos Int       Date:  2012-03-10       Impact factor: 4.507

Review 3.  Parathyroid hormone applications in the craniofacial skeleton.

Authors:  H L Chan; L K McCauley
Journal:  J Dent Res       Date:  2012-10-15       Impact factor: 6.116

4.  Alternative treatments for oral bisphosphonate-related osteonecrosis of the jaws: a pilot study comparing fibrin rich in growth factors and teriparatide.

Authors:  Alejandro Pelaz; Luis Junquera; Lorena Gallego; Luis García-Consuegra; Sonsoles Junquera; Carlos Gómez
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2014-07-01

Review 5.  Role of Teriparatide in Medication-Related Osteonecrosis of the Jaws (MRONJ).

Authors:  Yong-Dae Kwon; Deog-Yoon Kim
Journal:  Dent J (Basel)       Date:  2016-11-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.